Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 3
- 13F valueReported value at the end of Q2 2026
- $5.36M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in DKK.
- Revenue, FY2025
- DKK 309.1B
- +6.4% year over year
- Net income, FY2025
- DKK 102.4B
- +1.4% year over year
- Free cash flow, FY2025
- DKK 59.0B
- −20.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 11.4M
- Shares sold short
- Change
- −773.3K
- −6.4% vs. previous
- Days to cover
- 55.17
- At average daily volume
Superinvestors holding NONOF, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding NONOF at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Novo Nordisk A S insiders from Form 4, newest first.
No open-market purchases or sales by Novo Nordisk A S insiders are on file.
Top 10 13F holders, Q2 2026
See all 3 holdersThe largest institutional positions in Novo Nordisk A S at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cygnus Capital Advisors, LLC | 78,800 | $3.79M | 2.57% | +24,000+43.8% | Added |
| Generali Investments CEE, investicni spolecnost, a.s. | 27,399 | $1.32M | 0.06% | −2,920−9.6% | Reduced |
| Atlas Capital Advisors LLC | 5,218 | $250.9K | 0.03% | 00.0% | Unchanged |
Holders of 5% or more of NONOF
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Novo Nordisk A S.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 5.20%177.8M shares | – | Apr 23, 20251 filing | Apr 23, 2025 | SEC |
Politician trades
All politician trades in NONOF14 members of Congress reported 34 trades in Novo Nordisk A S since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 25, 2026 |  Kevin Hern House · OK | Sell (partial) | $1K-$15K |
| Sep 25, 2026 | Kevin Hern House · OK | Sell | $1K-$15K |
| Sep 17, 2026 |  Scott Franklin House · FL | Buy | $1K-$15K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $15K-$50K |
| Nov 21, 2025 |  Lisa C. McClain House · MI | Sell | $1K-$15K |
House · OK · Sep 25, 2026
Sell (partial)$1K-$15K
House · OK · Sep 25, 2026
Sell$1K-$15K
House · FL · Sep 17, 2026
Buy$1K-$15K
Senate · OK · Jul 21, 2026
Buy$15K-$50K
House · MI · Nov 21, 2025
Sell$1K-$15K